Pelvic exenteration for gynaecological tumours: achievements and unanswered questions

Lancet Oncology

Volumn 7, Issue 10, 2006, Pages 837-847

  Höckel, Michael ^a   Dornhöfer, Nadja ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE GENITAL TRACT CANCER; FEMALE GENITAL TRACT TUMOR; HEALING; HUMAN; PELVIS; PELVIS EXENTERATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL ANATOMY; SURGICAL TECHNIQUE; SURVIVAL TIME; SYMPTOMATOLOGY; TREATMENT CONTRAINDICATION; TUMOR RECURRENCE; UTERINE CERVIX CARCINOMA;

FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; PELVIC EXENTERATION; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33749041481     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70903-2     Document Type: Review

References (99)

1. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. Cancer 1 (1948) 177-183
2. Bricker E. Bladder substitution after pelvic evisceration. Surg Clin North Am 30 (1950) 1511-1521
3. Brunschwig A. What are the indications and results of pelvic exenteration?. JAMA 194 (1965) 274
4. Brunschwig A., and Barber H. Extended pelvic exenteration for advanced cancer of the cervix: long survivals following added resection of involved small bowel. Cancer 17 (1964) 1267-1270
5. Magrina J. Types of pelvic exenterations: a reappraisal. Gynecol Oncol 37 (1990) 363-366
6. Brunschwig A., and Barber H. Pelvic exenteration combined with resection of segments of bony pelvis. Surgery 65 (1969) 417-420
7. Wanebo H., and Marcove R. Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg 194 (1981) 458-471
8. Buchsbaum H., and White A. Omental sling for management of the pelvic floor following exenteration. Am J Obstet Gynecol 117 (1973) 407-412
9. Soper J., Berchuck A., Creasman W., and Clarke-Pearson D. Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol 35 (1989) 93-98
10. Kiselow M., Butcher Jr. H., and Bricker E. Results of the radical surgical treatment of advanced pelvic cancer: a fifteen-year study. Ann Surg 166 (1967) 428-436
11. Ingiulla W., and Cosmi E. Pelvic exenteration for advanced carcinoma of the cervix: some reflections on 241 cases. Am J Obstet Gynecol 99 (1967) 1083-1086
12. Ketcham A., Deckers P., Sugarbaker E., et al. Pelvic exenteration for carcinoma of the uterine cervix: a 15-year experience. Cancer 26 (1970) 513-521
13. Symmonds R., Pratt J., and Webb M. Exenterative operations: experience with 198 patients. Am J Obstet Gynecol 121 (1975) 907-918
14. Karlen J., and Piver M. Reduction of mortality and morbidity associated with pelvic exenteration. Gynecol Oncol 3 (1975) 164-167
15. Rutledge F., Smith J., Wharton J., and O'Quinn A. Pelvic exenteration: analysis of 296 patients. Am J Obstet Gynecol 129 (1977) 881-892
16. Averette H., Lichtinger M., Sevin B., and Girtanner R. Pelvic exenteration: a 15-year experience in a general metropolitan hospital. Am J Obstet Gynecol 150 (1984) 179-184
17. Rodriguez Cuevas H., Torres A., de la Garza M., et al. Pelvic exenteration for carcinoma of the cervix: analysis of 252 cases. J Surg Oncol 38 (1988) 121-125
18. Lawhead Jr. R., Clark D., Smith D., et al. Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981). Gynecol Oncol 33 (1989) 279-282
19. Morley G., Hopkins M., Lindenauer S., and Roberts J. Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 74 (1989) 934-943
20. Shingleton H., Soong S., Gelder M., et al. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 73 (1989) 1027-1034
21. Robertson G., Lopes A., Beynon G., and Monaghan J. Pelvic exenteration: a review of the Gateshead experience 1974-1992. Br J Obstet Gynaecol 101 (1994) 529-531
22. Lopez M., Standiford S., and Skibba J. Total pelvic exenteration: a 50-year experience at the Ellis Fischel Cancer Center. Arch Surg 129 (1994) 390-395
23. Shepherd J., Ngan H., Neven P., et al. Multivariate analysis of factors affecting survival in pelvic exenteration. Int J Gynecol Cancer 4 (1994) 361-370
24. Magrina J., Stanhope C., and Weaver A. Pelvic exenterations: supralevator, infralevator, and with vulvectomy. Gynecol Oncol 64 (1997) 130-135
25. Berek J., Howe C., Lagasse L., and Hacker N. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol 99 (2005) 153-159
26. Roos E., van Eijkeren M., Boon T., and Heintz A. Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer. Int J Gynecol Cancer 15 (2005) 624-629
27. Goldberg G., Sukumvanich P., Einstein M., et al. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003). Gynecol Oncol 101 (2006) 261-268
28. Höckel M. Ultra-radical compartmentalized surgery in gynaecological oncology. Eur J Surg Oncol (2006). published online May 9. DOI:10.1016/j.ejso.2006.03.040
29. Lopez M., and Barrios L. Evolution of pelvic exenteration. Surg Oncol Clin North Am 14 (2005) 587-606
30. Chang S., Cole E., Smith Jr. J., and Cookson M. Pathological findings of gynecologic organs obtained at female radical cystectomy. J Urol 168 (2002) 147-149
31. Plante M., and Roy M. Operative laparoscopy prior to a pelvic exenteration in patients with recurrent cervical cancer. Gynecol Oncol 69 (1998) 94-99
32. Köhler C., Tozzi R., Possover M., and Schneider A. Explorative laparoscopy prior to exenterative surgery. Gynecol Oncol 86 (2002) 311-315
33. Heald R., Husband E., and Ryall R. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence?. Br J Surg 62 (1982) 613-616
34. Höckel M., Horn L., and Fritsch H. Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study. Lancet Oncol 6 (2005) 751-756
35. Höckel M. Laterally extended endopelvic resection: novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall. Gynecol Oncol 91 (2003) 369-377
36. Karakousis C. Surgical treatment of locally progressive stage IIIB carcinoma of the cervix: use of the inverted "T" incision. Eur J Obstet Gynecol Reprod Biol 115 (2004) 216-218
37. Sharma S., Odunsi K., Driscoll D., and Lele S. Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute. Int J Gynecol Cancer 15 (2005) 475-482
38. Pomel C., Rouzier R., Pocard M., et al. Laparoscopic total pelvic exenteration for cervical cancer relapse. Gynecol Oncol 91 (2003) 616-618
39. Puntambekar S., Kudchadkar R., Gurjar A., et al. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases. Gynecol Oncol. published online Feb 27, 2006. DOI:10.1016/j.ygyno.2006.01.010
40. Ferron G., Querleu D., Martel P., Letourneur B., and Soulié M. Laparoscopy-assisted vaginal pelvic exenteration. Gynecol Oncol 100 (2006) 551-555
41. Hatch K., Gelder M., Soong S., et al. Pelvic exenteration with low rectal anastomosis: survival, complications, and prognostic factors. Gynecol Oncol 38 (1990) 462-467
42. Moutardier V., Houvenaeghel G., Lelong B., et al. Colorectal function preservation in posterior and total supralevator exenteration for gynecologic malignancies: an 89-patient series. Gynecol Oncol 89 (2003) 155-159
43. Mirhashemi R., Averette H., Estape R., et al. Low colorectal anastomosis after radical pelvic surgery: a risk factor analysis. Am J Obstet Gynecol 183 (2000) 1375-1379
44. Wheeless Jr. C., and Hempling R. Rectal J-pouch reservoir to decrease the frequency of tenesmus and defecation in low coloproctostomy. Gynecol Oncol 34 (1989) 379-382
45. Hancock K., Copeland L., Gershenson D., et al. Urinary conduits in gynecologic oncology. Obstet Gynecol 67 (1986) 680-684
46. Leissner J., Black P., Fisch M., et al. Colon pouch (Mainz pouch III) for continent urinary diversion after pelvic irradiation. Urology 56 (2000) 798-802
47. Segreti E., Morris M., Levenback C., et al. Transverse colon urinary diversion in gynecologic oncology. Gynecol Oncol 63 (1996) 66-70
48. Schmidt J., Buchsbaum H., and Jacobo E. Transverse colon conduit for supravesical urinary tract diversion. Urology 8 (1976) 542-546
49. Beddoe A., Boyce J., Remy J., et al. Stented versus nonstented transverse colon conduits: a comparative report. Gynecol Oncol 27 (1987) 305-315
50. Salom E., Mendez L., Schey D., et al. Continent ileocolonic urinary reservoir (Miami pouch): the University of Miami experience over 15 years. Am J Obstet Gynecol 190 (2004) 994-1003
51. Husain A., Curtin J., Brown C., et al. Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies. Gynecol Oncol 78 (2000) 208-211
52. Mannel R., Manetta A., Buller R., Braly P., Walker J., and Archer J. Use of ileocecal continent urinary reservoir in patients with previous pelvic irradiation. Gynecol Oncol 59 (1995) 376-378
53. Dottino P., Segna R., Jennings T., et al. The stapled continent ileocecal urinary reservoir in the surgical management of gynecologic malignancy. Gynecol Oncol 55 (1994) 185-189
54. Houvenaeghel G., Moutardier V., Karsenty G., et al. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Gynecol Oncol 92 (2004) 680-683
55. Ramirez P., Modesitt S., Morris M., et al. Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignancies. Gynecol Oncol 85 (2002) 285-291
56. Wilkin M., Horwitz G., Seetharam A., et al. Long-term complications associated with the Indiana pouch urinary diversion in patients with recurrent gynecologic cancers after high-dose radiation. Urol Oncol 23 (2005) 12-15
57. Ferreira U., Rodrigues Netto Jr. N., and Lucena R. The transverse colonic reservoir: the Unicamp technique. BJU Int 85 (2000) 486-489
58. Kato H., Igawa Y., Komiyama I., and Nishizawa O. Continent urinary reservoir formation with transverse colon for patients with pelvic irradiation. Int J Urol 9 (2002) 200-203
59. Ungar L., and Palfalvi L. Pelvic exenteration without external urinary or fecal diversion in gynecological cancer patients. Int J Gynecol Cancer 16 (2006) 364-368
60. Achauer B., Braly P., Berman M., and DiSaia P. Immediate vaginal reconstruction following resection for malignancy using the gluteal thigh flap. Gynecol Oncol 19 (1984) 79-89
61. Smith H., Genesen M., Runowicz C., and Goldberg G. The rectus abdominis myocutaneous flap: modifications, complications, and sexual function. Cancer 83 (1998) 510-520
62. Carlson J., Soisson A., Fowler J., et al. Rectus abdominis myocutaneous flap for primary vaginal reconstruction. Gynecol Oncol 51 (1993) 323-329
63. Carlson J., Carter J., Saltzman A., et al. Gynecologic reconstruction with a rectus abdominis myocutaneous flap: an update. Gynecol Oncol 61 (1996) 364-368
64. Mirhashemi R., Averette H., Lambrou N., et al. Vaginal reconstruction at the time of pelvic exenteration: a surgical and psychosexual analysis of techniques. Gynecol Oncol 87 (2002) 39-45
65. O'Connell C., Mirhashemi R., Kassira N., et al. Formation of functional neovagina with vertical rectus abdominis musculocutaneous (VRAM) flap after total pelvic exenteration. Ann Plast Surg 55 (2005) 470-473
66. Sood A., Cooper B., Sorosky J., et al. Novel modification of the vertical rectus abdominis myocutaneous flap for neovagina creation. Obstet Gynecol 105 (2005) 514-518
67. Jurado M., Bazan A., Elejabeitia J., et al. Primary vaginal and pelvic floor reconstruction at the time of pelvic exenteration: a study of morbidity. Gynecol Oncol 77 (2000) 293-297
68. Soper J., Rodriguez G., Berchuck A., and Clarke-Pearson D. Long and short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery: comparison of flap-specific complications. Gynecol Oncol 56 (1995) 271-275
69. Pursell S., Day Jr. T., and Tobin G. Distally based rectus abdominis flap for reconstruction in radical gynecologic procedures. Gynecol Oncol 37 (1990) 234-238
70. Ghulam N., McClinton S., Yong S., et al. Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev 2 (2005) CD003306
71. Orr Jr. J., Shingleton H., Hatch K., et al. Urinary diversion in patients undergoing pelvic exenteration. Am J Obstet Gynecol 142 (1982) 883-889
72. Wammack R., Wricke C., and Hohenfellner R. Long-term results of ileocecal continent urinary diversion in patients treated with and without previous pelvic irradiation. J Urol 167 (2002) 2058-2062
73. Tobin G., and Day T. Vaginal and pelvic reconstruction with distally based rectus abdominis myocutaneous flaps. Plast Reconstr Surg 81 (1988) 62-70
74. McCraw J., Massey F., Shanklin K., and Horton C. Vaginal reconstruction with gracilis myocutaneous flaps. Plast Reconstr Surg 58 (1976) 176-183
75. Turns D. Psychosocial issues: pelvic exenterative surgery. J Surg Oncol 76 (2001) 224-236
76. Roos E., de Graeff A., van Eijkeren M., et al. Quality of life after pelvic exenteration. Gynecol Oncol 93 (2004) 610-614
77. Hawighorst-Knapstein S., Fusshoeller C., Franz C., et al. The impact of treatment for genital cancer on quality of life and body image: results of a prospective longitudinal 10-year study. Gynecol Oncol 94 (2004) 398-403
78. 18FDG PET imaging in the management of cervical cancer. Gynecol Oncol 87 (2002) 90-97
79. 18F]fluoro-2-deoxy-D-glucose positron emission tomography. Cancer 100 (2004) 544-552
80. Miller B., Morris M., Levenback C., et al. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol 58 (1995) 202-205
81. Morris M., Alvarez R., Kinney W., and Wilson T. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol Oncol 60 (1996) 288-291
82. Crozier M., Morris M., Levenback C., et al. Pelvic exenteration for adenocarcinoma of the uterine cervix. Gynecol Oncol 58 (1995) 74-78
83. Hatch K., Shingleton H., Soong S., et al. Anterior pelvic exenteration. Gynecol Oncol 31 (1988) 205-216
84. Höckel M. Pelvic recurrences of cervical cancer: relapse pattern, prognostic factors, and the role of extended radical treatment. J Pelv Surg 5 (1999) 255-266
85. Mahé M., Gérard J., Dubois J., et al. Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: report of the French intraoperative group on 70 patients. Int J Radiat Oncol Biol Phys 43 (1996) 21-26
86. Gemignani M., Alektiar K., Leitao M., et al. Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers. Int J Radiat Oncol Biol Phys 50 (2001) 687-694
87. Höckel M., Schlenger K., Hamm H., et al. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer 77 (1996) 1918-1933
88. Benedet J., Odicino F., Maisonneuve P., et al. Carcinoma of the cervix uteri. Int J Gynaecol Obstet 83 suppl 1 (2003) 41-78
89. Kasamatsu T., Onda T., Yamada T., and Tsnuematsu R. Clinical aspects and prognosis of pelvic recurrence of cervical carcinoma. Int J Gynaecol Obstet 89 (2005) 39-44
90. Thomas G., Dembo A., Myhr T., et al. Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery. Int J Gynecol Cancer 3 (1993) 193-198
91. Ito H., Shigematsu N., Kawada T., et al. Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy. Gynecol Oncol 67 (1997) 154-161
92. Ijaz T., Eifel P., Burke T., and Oswald M. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma. Gynecol Oncol 70 (1998) 241-246
93. Deckers P., Ketcham A., Sugerbaker E., et al. Pelvic exenteration for primary carcinoma of the uterine cervix. Obstet Gynecol 37 (1971) 647-659
94. Kramer C., Peschel R., Goldberg N., et al. Radiation treatment of FIGO stage IVA carcinoma of the cervix. Gynecol Oncol 32 (1989) 323-326
95. Reid G., Morley G., Schmidt R., and Hopkins M. The role of pelvic exenteration for sarcomatous malignancies. Obstet Gynecol 74 (1989) 80-84
96. Lopes A., Poletto A., Carvalho A., et al. Pelvic exenteration and sphincter preservation in the treatment of soft tissue sarcomas. Eur J Surg Oncol 30 (2004) 972-975
97. Stanhope C., and Symmonds R. Palliative exenteration: what, when, and why?. Am J Obstet Gynecol 152 (1985) 12-16
98. Brophy P., Hoffman J., and Eisenberg B. The role of palliative pelvic exenteration. Am J Surg 167 (1994) 386-390
99. Finlayson C., and Eisenberg B. Palliative pelvic exenteration: patient selection and results. Oncology (Williston Park) 10 (1996) 479-484